BIT
TBPH icon

BlackRock Institutional Trust’s Theravance Biopharma TBPH Stock Holding History

BlackRock Institutional Trust’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$32.7M Buy
1,026,199
+146,247
+17% +$4.54M ﹤0.01% 1607
2016
Q3 		$31.9M Buy
879,952
+73,601
+9% +$2.05M 0.01% 1575
2016
Q2 		$18.3M Buy
806,351
+82,063
+11% +$1.77M ﹤0.01% 1902
2016
Q1 		$13.6M Buy
724,288
+40,431
+6% +$662K ﹤0.01% 2066
2015
Q4 		$11.2M Buy
683,857
+27,558
+4% +$437K ﹤0.01% 2248
2015
Q3 		$7.21M Sell
656,299
-68,448
-9% -$872K ﹤0.01% 2501
2015
Q2 		$9.44M Sell
724,747
-12,320
-2% -$191K ﹤0.01% 2445
2015
Q1 		$12.8M Buy
737,067
+9,541
+1% +$175K ﹤0.01% 2230
2014
Q4 		$10.9M Buy
727,526
+17,770
+3% +$310K ﹤0.01% 2313
2014
Q3 		$16.4M Buy
709,756
+54,472
+8% +$1.58M ﹤0.01% 2005
2014
Q2 		$20.9M Buy
+655,284
New +$19.7M ﹤0.01% 1931

Other funds holding TBPH

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

BlackRock Institutional Trust's TBPH Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Theravance Biopharma (TBPH) stake by 17% in Q4 2016, buying an estimated $4.54M and bringing the position to 1,026,199 shares worth $32.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1607.

BlackRock Institutional Trust first reported a position in TBPH in Q2 2014 and has held it in 11 quarters since. 98 funds tracked by Wall St. Rank hold TBPH as of Q4 2016.

  • BlackRock Institutional Trust held 1,026,199 shares of Theravance Biopharma worth $32.7M as of Q4 2016.
  • BlackRock Institutional Trust bought 146,247 Theravance Biopharma shares in Q4 2016, an estimated $4.54M.
  • Theravance Biopharma made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1607 holding.
  • BlackRock Institutional Trust first reported a position in Theravance Biopharma in Q2 2014 and has held it in 11 quarters since.
  • 98 funds tracked by Wall St. Rank held Theravance Biopharma as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.